Daisy Berisha
Clinical focus in primary eye care and ocular disease including diabetic eye examinations, glaucoma screenings and treatments, anterior segment disease as well as pediatric eye examinations for children aged 5 and up.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Berisha takes a special interest in dry eye disease, screening and management of glaucoma and diabetic eye disease, and finding the ideal corrective eyewear for each patient.<quillbot-extension-portal></quillbot-extension-portal>
Melissa Yao
<p>Routine and Complex Cataract Surgery</p><p>Medical and Surgical Treatment of Glaucoma</p><p>Comprehensive Ophthalmology</p>
<p>Glaucoma</p><p>Resident Education</p>
<p>Wen-Jeng M. Yao, MD, is an Attending Physician and Associate Professor in Ophthalmology at Montefiore Einstein. Her clinical focus is on routine and complex cataract surgery, medical and surgical treatment of glaucoma, and comprehensive ophthalmology. She enjoys establishing long-lasting relationships with her patients, delivering the highest quality clinical and surgical care in ophthalmology, and teaching residents who are training to become future ophthalmologists.</p><p>After receiving her Bachelor of Arts degree at Cornell University, Dr. Yao attended Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, earning her Doctor of Medicine in 2006. She began her postdoctoral training with a yearlong internship at Saint Peters University Hospital, followed by her residency in ophthalmology at George Washington University in 2010. In 2011, she completed her surgical glaucoma fellowship at Columbia Presbyterian Hospital.</p><p>Dr. Yao’s research interests involve identifying epidemiological associations of glaucoma and advancing surgical and laser techniques for glaucoma therapy. Her work has been shared through peer-reviewed journals, book chapters, abstracts and poster presentations.</p><p>Dr. Yao is board certified and is a member of the American Academy of Ophthalmology and the American Glaucoma Society. She was listed as a Castle Connelly Top Doctor in 2021, 2022 and 2023.</p>
Danny Woo
Kara L. Watts
Clinical practice focuses on BPH, endourology, and prostate cancer detection and ablation.<quillbot-extension-portal></quillbot-extension-portal>
Work on quality improvement in healthcare and active surveillance and focal ablation in prostate cancer.<quillbot-extension-portal></quillbot-extension-portal>
<p>Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program.</p><p>Dr. Watts' clinical practice focuses on BPH, endourology, and prostate cancer detection and ablation. She also offers image-guided focal ablation for localized prostate cancer. She has a particular interest in active surveillance of prostate cancer and incorporating imaging modalities, particularly MRI imaging, into the diagnosis and treatment of localized prostate cancer.</p><p>Dr. Watts has numerous peer-reviewed publications, written several book chapters and co-edited a textbook. She has presented both nationally and internationally at various conferences and with the AUA regarding her work on quality improvement in healthcare and active surveillance and focal ablation in prostate cancer. She is involved in several national and international committees and editorial boards, including the AUA Quality Improvement and Patient Safety Committee, the Prostate Cancer Active Surveillance Research Initiative Advisory Committee, and the Urology Times Editorial Board.</p>
Alex B. Theventhiran
<p>Medical and surgical management of glaucoma, anterior segment surgery and complex cataracts.</p>
<p>Focus on optimization of diagnosis and treatment of glaucoma; analyzing and optimizing patient outcomes post surgery; analysis of post-operative treatment modalities; minimally invasive glaucoma surgery outcomes and analysis of post surgical findings/complication.</p>
Asli S. Sucu
Brian D. Spund
Sumeet Singh-Tan
Anurag Shrivastava
<p>Glaucoma/Anterior Segment</p>
<p>Dr. Shrivastava is fellowship trained in glaucoma, and provides comprehensive eyecare for patients primarily with anterior segment disease.</p>
<p><span style="color:red;"> </span></p><p>Dr. Shrivastava’s clinical research is primarily focused on structural and functional deficits in glaucoma, along with advancements in drug delivery and trials involving novel molecules and therapeutic targets. As the former Program Director for the Ophthalmology Residency Program, and as the current Assistant Dean for Montefiore Medical Center, Dr. Shrivastava is additionally very active in developing and researching advancements in medical educational resources.</p>
<p>Anurag Shrivastava, MD serves as Assistant Dean, Montefiore Medical Center and Associate Designated Institutional Officer, Graduate Medical Education. He is an attending physician, Glaucoma and Associate Professor, Ophthalmology and Visual Sciences at Montefiore Einstein. Dr. Shrivastava is fellowship trained in glaucoma, and provides comprehensive eye care for patients primarily with anterior segment disease.</p><p>In 1996, Dr. Shrivastava received his Bachelor of Arts in psychology and his Bachelor of Science in neuroscience from University of Rochester with high honors. He later pursued his medical education at State University of New York, Upstate Medical University, Syracuse, earning his Doctor of Medicine in 2003. After completing a transitional year internship at Weill Cornell New York Hospital Queens, Dr. Shrivastava completed his ophthalmology residency at Einstein in 2007, acting as Chief Resident in his final year. He continued his medical training with a yearlong glaucoma and advanced surgical technique fellowship at Stanford University, completing it in 2008.</p><p>Dr. Shrivastava’s clinical research is primarily focused on structural and functional deficits in glaucoma, along with the interplay between cataract surgery and glaucoma management and advancements in drug delivery and trials involving novel molecules and therapeutic targets. He is very active in developing and researching advancements in medical educational resources. Dr. Shrivastava is active in the Office for Clinical Trials, and has been highly involved in cutting edge clinical trials at the forefront of glaucoma management, including early phase drug and device trials along with sustained release drug delivery technologies.</p><p>Dr. Shrivastava has been recognized many times for his contributions to excellence at Montefiore Einstein, receiving the Montefiore Annual President’s Award in 2015 and being inducted into Leo M. Davidoff Einstein Society for highest tier of medical educators at the College of Medicine in 2022. He is a member of several professional organizations including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Glaucoma Society.</p>